23andMe is shutting down its therapeutics development division and plans to seek out buyers to find a new home for its in-house pipeline of DNA-informed immuno-oncology antibody drugs.
Screw all you fools. I mean, look at this DNA sequence right here… One allele for myopia, the other for twisted eye sockets and one eye way larger than the other…which one would win? Myopia ofcourse! Nah. You guys are totally screwed. So we give up. Go ahead keep fucking the weirdoes! It’s fine by us!
Screw all you fools. I mean, look at this DNA sequence right here… One allele for myopia, the other for twisted eye sockets and one eye way larger than the other…which one would win? Myopia ofcourse! Nah. You guys are totally screwed. So we give up. Go ahead keep fucking the weirdoes! It’s fine by us!